These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1493920)

  • 1. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.
    Hartnell A; Kay AB; Wardlaw AJ
    Immunology; 1992 Dec; 77(4):488-93. PubMed ID: 1493920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.
    Hartnell A; Robinson DS; Kay AB; Wardlaw AJ
    Immunology; 1993 Oct; 80(2):281-6. PubMed ID: 8262555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone up-regulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes.
    Hawrylowicz CM; Guida L; Paleolog E
    Immunology; 1994 Oct; 83(2):274-80. PubMed ID: 7835947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.
    Walsh GM; Hartnell A; Wardlaw AJ; Kurihara K; Sanderson CJ; Kay AB
    Immunology; 1990 Oct; 71(2):258-65. PubMed ID: 2228026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
    Wallen N; Kita H; Weiler D; Gleich GJ
    J Immunol; 1991 Nov; 147(10):3490-5. PubMed ID: 1940348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1.
    Newton R; King EM; Gong W; Rider CF; Staples KJ; Holden NS; Bergmann MW
    Biochem J; 2010 Mar; 427(1):113-24. PubMed ID: 20100175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils.
    Hallsworth MP; Litchfield TM; Lee TH
    Immunology; 1992 Feb; 75(2):382-5. PubMed ID: 1551701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
    Sale R; Sabatini F; Silvestri M; Serpero L; Petecchia L; Rossi GA
    Int Immunopharmacol; 2004 Dec; 4(13):1687-96. PubMed ID: 15454120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
    Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
    Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of HLA class II, but not intercellular adhesion molecule 1 (ICAM-1) by granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin-3 (IL-3) in synergy with dexamethasone.
    Sadeghi R; Feldmann M; Hawrylowicz C
    Eur Cytokine Netw; 1992; 3(4):373-80. PubMed ID: 1358241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils.
    Bates ME; Liu LY; Esnault S; Stout BA; Fonkem E; Kung V; Sedgwick JB; Kelly EA; Bates DM; Malter JS; Busse WW; Bertics PJ
    Am J Respir Cell Mol Biol; 2004 May; 30(5):736-43. PubMed ID: 14630612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of dexamethasone on mRNA expression of interleukin-5, interleukin-3 and granulocyte-macrophage colony-stimulating factor receptors in eosinophils of guinea pig asthma model].
    Li Z; Wang C; Qian G
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):542-7. PubMed ID: 11758170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor.
    Lamas AM; Leon OG; Schleimer RP
    J Immunol; 1991 Jul; 147(1):254-9. PubMed ID: 2051022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils.
    Wang P; Wu P; Cheewatrakoolpong B; Myers JG; Egan RW; Billah MM
    J Immunol; 1998 May; 160(9):4427-32. PubMed ID: 9574547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1.
    Campbell IK; Novak U; Cebon J; Layton JE; Hamilton JA
    J Immunol; 1991 Aug; 147(4):1238-46. PubMed ID: 1714478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
    Carlson M; Peterson C; Venge P
    Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.
    Tomioka K; MacGlashan DW; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1993 Nov; 151(9):4989-97. PubMed ID: 8409452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.